Passage Bio Inc (PASG) Return on Assets ROA from the second quarter of 2026 to second quarter of 2025 and for the year 2026, Average High and Low, Fundamental Ratios from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Passage Bio Inc   (NASDAQ: PASG)


Passage Bio Inc 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Passage Bio Inc 's ROA in the second quarter of 2026?
Passage Bio Inc recorded a cumulative net loss of $-36 million during 12 months ending in the second quarter of 2026, resulting in a negative return on assets (ROA) of -72.92%.

However, within the Healthcare sector 673 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 4022, from total ROA ranking in the first quarter of 2026 at 4702.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Total Assets Change -68.21 % -57.61 % -30.91 % -33.64 % -27.38 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -36 -38 -46 -45 -57
Return On Assets (TTM) -72.92 % -59.78 % -60.36 % -54.95 % -61.95 %
PASG's Total Ranking # 4022 # 4702 # 4048 # 4183 # 4266
Total Assets (TTM) in million 25 36 62 74 79
Seq. Total Assets Change -30.96 % -41.46 % -16.02 % -6.36 % -7.92 %
Seq. Net Income Change - - - - -

PASG's 5 Years Annual ROA >> Back to PASG Management Effectiveness >> Compare PASG ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 100
Sector # 674
Overall # 4106

Return On Assets Statistics
High Average Low
-30.81 %
-51.21 %
-72.92 %
(Dec 31 2020)   (Jun 30 2026)



  News about Passage Bio Inc Return on Assets ROA

Passage Bio Unveils Promising Interim Data in FTD-GRN Study Amid Financial Challenges

Passage Bio, Inc. a clinical-stage genetic medicine company, is poised to present interim data from its upliFT-D study at the upcoming 14th International Conference on Frontotemporal Dementias (ISFTD2024). This study focuses on patients with frontotemporal dementia caused by GRN mutations (FTD-GRN), and initial results have generated optimism within the scientific community and among potential investors.The upliFT-D study aims to evaluate the safety and efficacy of Passage Bio s gene therapy approach in treating FTD-GRN, a rare and aggressive form of dementia. Preliminary findings suggest that there may be a favorable response in Cohort 1 patients, potentially paving the way for future advancements in the treatment of this challenging condition.



Financial Statements
Passage Bio Inc 's Assets $ 25 million PASG's Balance sheet
Passage Bio Inc 's Income $ -8 million Quarterly PASG's Income Statement
PASG's Income by Division See PASG's Income by Division



Annual Return On Assets (Dec 31 2025)
FY 2025		 (Dec 31 2024)
FY 2024		 (Dec 31 2023)
FY 2023		 (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021
Y / Y Total Assets Change -30.91 % -33.35 % -39.77 % -36.76 % 8.25 %
Total Assets in million 62 90 135 225 355
Y / Y Net Income Change - - - - -
Net Income in million -46 -65 -102 -136 -185
Annual Return On Assets -73.09 % -71.85 % -75.46 % -60.62 % -52.21 %

PASG's 5 Years Annual ROA >> Back to PASG Management Effectiveness >> Compare PASG ROA to its Competitors



More Return On Assets Ratios
PASG's' Return on Assets at Yahoo Finance
Biotechnology & Pharmaceuticals Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
PASG's Roa Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for PASG's Competitors
Subscribers only: Roa for Passage Bio Inc 's Suppliers
Subscribers only: Return On Assets for PASG's Customers

You may also want to know
PASG's Roi PASG's Inventory Turnover Ratio PASG's Growth Rates PASG's Dividend Comparisons
PASG's Profitability Ratios PASG's Asset Turnover Ratio PASG's Dividend Growth
PASG's Roe PASG's Valuation Ratios PASG's Financial Strength Ratios PASG's Dividend Payout Ratio



Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector ROA

Date modified: 2026-08-14T20:52:45+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.